Spontaneous Intracranial Hypotension Updates
Neurology® Podcast
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade. Disclosures can be found at .
info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease
Neurology® Podcast
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at .
info_outline
May 2025 Recall: Topics on Myasthenia Gravis
Neurology® Podcast
The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries...
info_outline
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Neurology® Podcast
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in . Disclosures can be found at .
info_outline
Women With Genetic Epilepsies
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Paula Marques about sex differences in genetically determined epilepsies. Read the related article in . Disclosures can be found at .
info_outline
Understanding the Classification of Headaches and the Science Behind Them
Neurology® Podcast
Dr. Tesha Monteith talks with Dr. Peter Goadsby about advances in headache science and classification. Read the editorial about . Disclosures can be found at .
info_outline
BTK Inhibitors in Multiple Sclerosis Treatment
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis. Read the related article on Tolebrutinib versus Teriflunomide in . Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in . Disclosures can be found at .
info_outline
The Landscape of Adult Neurology Residency Didactic Curricula in the United States
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Harry W. Sutherland about diversity in teaching methods, the balance between clinical responsibilities and educational opportunities, and innovative models like the academic half day. Read the related article in . Disclosures can be found at .
info_outline
Characterizing Prodrome in Migraine
Neurology® Podcast
Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Read the related article with . Disclosures can be found at .
info_outline
Reducing Health Care Costs with Functional Seizures Clinic Referral
Neurology® Podcast
Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with . Disclosures can be found at .
info_outlineThe December 2023 replay wraps up the year with four previously posted episodes on neurocritical care. The episode begins with an interview with Dr. Karin Diserens on subtle clinical signs in unresponsive brain-impaired individuals. The episode continues with an interview with Dr. David Greer on updated brain death guidelines. The next interview is with Dr. Monica Lemmon on communicating information about neurologic prognosis. The fourth and final interview is with Drs. Susanne Muehlschlegel and Adeline Goss on the prognostic language used in critical neurologic illness.
Related Podcast Links:
Subtle Clinical Signs in Unresponsive Brain Impairment: https://directory.libsyn.com/episode/index/id/27124839
Updated Pediatric and Adult BD/DNC Consensus Guidelines: https://directory.libsyn.com/episode/index/id/28537073
A Parent-Informed Approach to Communicating Neurologic Prognosis in Infants: https://directory.libsyn.com/episode/index/id/25988781
Language Use in Neurocritical Illness Prognostication: https://directory.libsyn.com/episode/index/id/28137575
Related Article Links:
A Focus on Subtle Signs and Motor Behavior to Unveil Awareness in Unresponsive Brain-Impaired Patients: The Importance of Being Clinical: https://doi.org/10.1212/WNL.0000000000207067
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM: https://doi.org/10.1212/WNL.0000000000207740
The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions: https://doi.org/10.1212/WNL.0000000000201600
Prognostic Language in Critical Neurologic Illness: A Multicenter Mixed-Methods Study: https://doi.org/10.1212/WNL.0000000000207462
Disclosures can be found at Neurology.org